Also known as Aptivus
Tipranavir, or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer-Ingelheim under the trade name Aptivus. It is administered with ritonavir in combination therapy to treat HIV infection and is given as two 250 mg capsules together with 200 mg of ritonavir twice daily.Source: Wikipedia
Estimated Total Cost: $974.14 for an average of 28 days supply
Patients are most commonly prescribed tipranavir to treat human immunodeficiency virus infection (hiv), rabies, blastomycosis, and west nile virus.
Patients taking tipranavir most commonly experience side effects like diarrhea, nausea, and fever.